Related references
Note: Only part of the references are listed.Deficiency of Jamc Leads to Congenital Nuclear Cataract and Activates the Unfolded Protein Response in Mouse Lenses
Jiani Li et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2022)
A novel homozygous variant in JAM3 gene causing hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts (HDBSCC) with neonatal onset
Domenico Umberto De Rose et al.
NEUROLOGICAL SCIENCES (2021)
Biallelic loss-of-function mutations in JAM2 cause primary familial brain calcification
Zhidong Cen et al.
BRAIN (2020)
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification
Lucia Schottlaender et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2020)
JAM3 functions as a novel tumor suppressor and is inactivated by DNA methylation in colorectal cancer
Dan Zhou et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Dynamic trafficking and turnover of JAM-C is essential for endothelial cell migration
Katja B. Kostelnik et al.
PLOS BIOLOGY (2019)
Jam3 promotes migration and suppresses apoptosis of renal carcinoma cell lines
Xudong Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Loss of JAM-C leads to impaired esophageal innervations and megaesophagus in mice
M. Ye et al.
DISEASES OF THE ESOPHAGUS (2016)
An after after-cataract: A curious case of visual axis re-opacification
Jay Kalliath et al.
SAUDI JOURNAL OF OPHTHALMOLOGY (2016)
JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix
Aijun Yin et al.
ONCOTARGET (2015)
A novel rearrangement of occludin causes brain calcification and renal dysfunction
Marissa A. LeBlanc et al.
HUMAN GENETICS (2013)
Delineation of the Clinical, Molecular and Cellular Aspects of Novel JAM3 Mutations Underlying the Autosomal Recessive Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Congenital Cataracts
Nadia A. Akawi et al.
HUMAN MUTATION (2013)
Prevalence and risk factors for Auditory Neuropathy Spectrum Disorder in a screened newborn population at risk for hearing loss
Ireneusz Bielecki et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2012)
Junctional Adhesion Molecule (JAM)-C Deficient C57BL/6 Mice Develop a Severe Hydrocephalus
Lena Wyss et al.
PLOS ONE (2012)
The genetic basis of auditory neuropathy spectrum disorder (ANSD)
Vinaya K. C. Manchaiah et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2011)
Recessive Mutations in the Gene Encoding the Tight Junction Protein Occludin Cause Band-like Calcification with Simplified Gyration and Polymicrogyria
Mary C. O'Driscoll et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
A Homozygous Mutation in the Tight-Junction Protein JAM3 Causes Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Congenital Cataracts
Ganeshwaran H. Mochida et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Deletion of JAM-C, a Candidate Gene for Heart Defects in Jacobsen Syndrome, Results in a Normal Cardiac Phenotype in Mice
Maoqing Ye et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Expression and function of junctional adhesion molecule-C in myelinated peripheral nerves
Christoph Scheiermann et al.
SCIENCE (2007)
Novel distribution of junctional adhesion molecule-C in the neural retina and retinal pigment epithelium
Lauren L. Daniele et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke
Igor Sibon et al.
ANNALS OF NEUROLOGY (2007)
Spermatid differentiation requires the assembly of a cell polarity complex downstream of junctional adhesion molecule-C
G Gliki et al.
NATURE (2004)
The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1
S Santoso et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor
MP Arrate et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
